Evidence map›Paper›PMID 39846749›Full record

ArticleApplied and environmental microbiology2025

Physico-chemical properties and substrate specificity of α-(1→3)-d-glucan degrading recombinant mutanase from

Olga A Sinitsyna, Pavel V Volkov, Ivan N Zorov, Alexandra M Rozhkova, Oleg V Emshanov, Yulia M Romanova, Bozhena S Komarova, Natalia S Novikova, Nikolay E Nifantiev, Arkady P Sinitsyn

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Applied and environmental microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Olga A SinitsynaDepartment of Chemistry, M.V. Lomonosov Moscow State University, Moscow, Russia.ORCID 0000-0001-5424-7402
Pavel V VolkovFederal Research Centre «Fundamentals of Biotechnology» of the Russian Academy of Sciences, Moscow, Russia.
Ivan N ZorovDepartment of Chemistry, M.V. Lomonosov Moscow State University, Moscow, Russia.
Alexandra M RozhkovaFederal Research Centre «Fundamentals of Biotechnology» of the Russian Academy of Sciences, Moscow, Russia.
Oleg V EmshanovLLC BFR Laboratories, Moscow, Russia.
Yulia M RomanovaThe National Research Center for Epidemiology and Microbiology named after Honorary Academician N.F. Gamaleya of the Ministry of Health of the Russian Federation, Moscow, Russia.
Bozhena S KomarovaLaboratory of Glycoconjugate Chemistry, N.D. Zelinsky Institute of Organic Chemistry, Russian Academy of Sciences, Moscow, Russia.
Natalia S NovikovaLaboratory of Glycoconjugate Chemistry, N.D. Zelinsky Institute of Organic Chemistry, Russian Academy of Sciences, Moscow, Russia.
Nikolay E NifantievLaboratory of Glycoconjugate Chemistry, N.D. Zelinsky Institute of Organic Chemistry, Russian Academy of Sciences, Moscow, Russia.ORCID 0000-0002-0727-4050
Arkady P SinitsynDepartment of Chemistry, M.V. Lomonosov Moscow State University, Moscow, Russia.

Funding

Ministry of Science and Higher Education of the Russian Federation (Minobrnauki of Russia) 122041100066-7Russian Science Foundation (RSF) 19-73-30017-P
6 · The paper itself

Abstract

The gene IMPORTANCE: The manuscript describes the properties of a novel recombinant GH71 mutanase Mut A from

Indexed as

Fungal ProteinsGlucansGlycoside HydrolasesHypocrealesPenicilliumCloning, MolecularHydrogen-Ion ConcentrationHydrolysisKineticsRecombinant ProteinsSubstrate SpecificityFungal ProteinsGlucansGlycoside HydrolasesRecombinant Proteinsbacterial biofilmsmutanaseoligo-α-(1→3)-D-glucoside substratesPenicillium verruculosumα-(1→3)-d-glucanα-1,3-glucanase

Identifiers

PMID39846749
PMCPMC11837517

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.